<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="evaluated the feasibility of a randomized, placebo-controlled trial using intravenous" exact="ribavirin" post="in patients with suspected severe RVF, but no official"/>
 <result pre="Pathogens Laboratory Network in 2016, it was briefly mentioned that" exact="ribavirin" post="was used without efficacy in Saudi Arabia [101]. Evidence"/>
 <result pre="was used without efficacy in Saudi Arabia [101]. Evidence suggests" exact="ribavirin" post="efficacy in animal models [102, 103], but it failed"/>
 <result pre="case reports of encephalitis, the use of amantadine, rifampicin, and" exact="dexamethasone" post="[72], doubled prednisone doses with a stop in immunosuppressive"/>
 <result pre="encephalitis, the use of amantadine, rifampicin, and dexamethasone [72], doubled" exact="prednisone" post="doses with a stop in immunosuppressive drugs [74], and"/>
 <result pre="prednisone doses with a stop in immunosuppressive drugs [74], and" exact="phenytoin" post="[70] were reported but not evaluated precisely. Early renal"/>
 <result pre="l’homme. https://studylibfr.com/doc/1012718/fièvre-de-la-vallée-du-rift-en-afrique–aspects-cliniques. Accessed 30 June 2019. 102.KendeMAlvingCRRillWLSwartzGMCanonicoPGEnhanced efficacy of liposome-encapsulated" exact="ribavirin" post="against Rift Valley fever virus infection in miceAntimicrob Agents"/>
 <result pre="the literature and proposed guidelines for the use of oral" exact="ribavirin" post="as postexposure prophylaxis for Lassa feverClin Infect Dis2010511435144110.1086/65731521058912 106.IslamMKStrandMSaleebMSvenssonRBaranczewskiPArturssonPet"/>
 <result pre="fever virus infection and reduces delayed-onset neurologic disease observed with" exact="ribavirin" post="treatmentAntiviral Res2014104849210.1016/j.antiviral.2014.01.01624486952 108.SmeeDFJungK-HWestoverJGowenBB2′-Fluoro-2′-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses"/>
</results>
